The average of price targets set by Wall Street analysts indicates a potential upside of 58.6% in Kiniksa Pharmaceuticals (KNSA). While the effectiveness of this highly sought-after metric is ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

Nikhil Lalwani, President and CEO of ANI stated, "This transaction reflects our commitment to strengthening our Retina portfolio and maximizing the long-term value of ILUVIEN and YUTIQ. By eliminating ...

Pharmaceutical companies looked at this tax ... in Ireland or Singapore without changing real imports. And it would mean that the companies would have to pay tax in the U.S. at the headline ...

Encouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat cancers ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

Thanks to a loophole in the Federal Food, Drug, and Cosmetic Act of 1938, some of the “drugs” you can buy at pharmacies are ...

LUTTERAL: Yes. Dua Lipa – you're a Dua Lipa fan, I know that. PRIME MINISTER: I am indeed. And I hear from my Brisbane friends that travelling north there, to where the current venue is – PRIME ...

Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Orphan Drug Report highlighting forecasts for the orphan drug market out to 2030. The 2025 ...

David Bonfiglio’s small town pharmacy is getting busier and busier, but staff and revenue are shrinking. With low ...

As the pharmaceutical industry has operations and ... including specific incident types or wider categories, meaning you can drill down into exactly what you’re interested in, and avoid being ...